Share Name Share Symbol Market Type Share ISIN Share Description
Immunodiagnostic Systems Hldgs LSE:IDH London Ordinary Share GB00B01YZ052 ORD 2P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -3.00p -1.44% 208.00p 200.00p 216.00p 208.00p 208.00p 208.00p 0 08:00:10
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Health Care Equipment & Services 37.9 0.9 4.2 49.5 59.87

Immunodiagnostic Systems Hldgs PLC Result of AGM

26/07/2018 5:59pm

UK Regulatory (RNS & others)


Immunodiagnostic Systems (LSE:IDH)
Historical Stock Chart

6 Months : From May 2018 to Nov 2018

Click Here for more Immunodiagnostic Systems Charts.

TIDMIDH

RNS Number : 9400V

Immunodiagnostic Systems Hldgs PLC

26 July 2018

Results of AGM

Immunodiagnostic Systems Holdings PLC

26 July 2018

Immunodiagnostic Systems Holdings plc

Results of AGM

Immunodiagnostic Systems Holdings PLC ("the Company"), a specialist producer of manual and automated diagnostic testing kits and instruments for the clinical and research markets, announces the results of its Annual General Meeting (the "Meeting") that was held at 2pm today.

Trading Update

At the meeting the Chairman, Dr Burkhard Wittek, provided a business update at the Meeting and a copy of the statement has been made available on the Company's website.

Voting Results

All resolutions put to the Meeting were decided on a show of hands and all were duly passed.

For information, details of the proxy voting are shown below:

 
              Resolution                 Votes For                 Votes                   Votes                   Votes 
                                                                   For                     Against                 Withheld 
                                                                   (as % of                (as % of 
                                                                   votes                   votes 
                                                                   cast)                   cast) 
      1. To receive the 
       accounts 
       for the year ended 
       31 
       March 2018 
       together with 
       the report of the 
       Directors 
       and of the Auditor 
       thereon.                          15,827,938                100.00%                 0.00%                   0 
                           ------------------------  ----------------------  ----------------------  ---------------------- 
      2. To declare a 
       final 
       dividend for the 
       year 
       ended 31 March 
       2018.                             15,827,938                100.00%                 0.00%                   0 
                           ------------------------  ----------------------  ----------------------  ---------------------- 
      3. To elect as a 
       director 
       of the Company Mr 
       Jaap 
       Stuut.                            15,027,938                94.95%                  5.05%                   0 
                           ------------------------  ----------------------  ----------------------  ---------------------- 
      4. To elect as a 
       director 
       of the Company Dr 
       Burkhard 
       Wittek.                           14,798,137                93.53%                  6.47%                   5,624 
                           ------------------------  ----------------------  ----------------------  ---------------------- 
      5. To elect as a 
       director 
       of the Company Mr 
       Peter 
       Williamson.                       15,826,889                99.99%                  0.01%                   620 
                           ------------------------  ----------------------  ----------------------  ---------------------- 
      6. To re-appoint 
       Ernst 
       & Young LLP as 
       Auditor 
       of the Company.                   15,027,938                94.95%                  5.05%                   0 
                           ------------------------  ----------------------  ----------------------  ---------------------- 
      7. To authorize the 
       Directors 
       of the Company to 
       determine 
       the remuneration 
       of the 
       Auditor of the 
       Company.                          15,827,938                100.00%                 0.00%                   0 
                           ------------------------  ----------------------  ----------------------  ---------------------- 
      8. To approve the 
       Directors' 
       Remuneration 
       Report for 
       the financial year 
       ended 
       31 March 2018.                    15,827,888                100.00%                 0.00%                   50 
                           ------------------------  ----------------------  ----------------------  ---------------------- 
      9. To authorise the 
       Directors 
       to allot relevant 
       securities.                       15,827,938                100.00%                 0.00%                   0 
                           ------------------------  ----------------------  ----------------------  ---------------------- 
      10. To authorise 
       the 
       disapplication of 
       pre-emption 
       rights in 
       accordance 
       with section 570 
       of the 
       Companies Act 
       2006.                             14,683,746                92.77%                  7.23%                   0 
                           ------------------------  ----------------------  ----------------------  ---------------------- 
      11. To authorise 
       the 
       Directors to make 
       market 
       purchases.                        15,827,938                100.00%                 0.00%                   0 
                           ------------------------  ----------------------  ----------------------  ---------------------- 
 

The full text of each of the resolutions is set out in the notice of Annual General Meeting, copies of which are available on the IDS website (www.idsplc.com).

For further information:

   Immunodiagnostic Systems Holdings plc                          Tel : +44 (0)191 5190660 

Paul Martin, Group Finance Director

Peel Hunt LLP Tel : +44 (0)207 418 8900

James Steel

Oliver Jackson

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

RAGSEAFMMFASEIW

(END) Dow Jones Newswires

July 26, 2018 12:59 ET (16:59 GMT)

1 Year Immunodiagnostic Systems Chart

1 Year Immunodiagnostic Systems Chart

1 Month Immunodiagnostic Systems Chart

1 Month Immunodiagnostic Systems Chart
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:33 V:gb D:20181119 16:00:30